Search Within

Matthew David Hellmann

  1. "MSK Grad Students"
Formats
  1. Journal Article (11)
  2. Meeting Abstract (4)
Groups
  1. Department of Medicine (15)
  2. MSK Grad Students (15)
  3. Solid Tumor Oncology Division (15)
  4. Thoracic Oncology (15)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (14)
  6. GSK Faculty (14)

More Groups

People
  1. Charles Rudin (7)
  2. Hira Rizvi (6)
  3. Jedd Wolchok (6)
  4. Taha Merghoub (6)
  5. Barry Taylor (5)
  6. David Solit (5)

More People

Years
  1. 2023 (2)
  2. 2022 (3)
  3. 2021 (1)
  4. 2020 (2)
  5. 2019 (3)
  6. 2018 (2)

More Years

Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Experimental Medicine (2)
  3. Nature (2)
  4. Cancer Cell (1)
  5. Cancer Epidemiology Biomarkers and Prevention (1)
  6. Cancer Research (1)

More Publications

Publishers
  1. Nature Publishing Group (4)
  2. American Association for Cancer Research (2)
  3. American Society of Clinical Oncology (2)
  4. Cell Press (2)
  5. Rockefeller University Press (2)
  6. Biomed Central Ltd (1)

More Publishers

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Neopeptide diversity and similarity to the unmutated immunopeptidome is associated with response to immune checkpoint blockade therapy
    Meeting Abstract

    Klatt, M.; Molvi, Z.; Panageas, K.; Wells, D.; Hellmann, M.; Merghoub, T.; Wolchok, J.; O'Reilly, R.; Keller, U.; Scheinberg, D.
    Oncology Research and Treatment (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Germline pathogenic variants impact clinicopathology of advanced lung cancer
    Journal Article

    Mukherjee, S.; Bandlamudi, C.; Hellmann, M. D.; Kemel, Y.; Drill, E.; Rizvi, H.; Tkachuk, K.; Khurram, A.; Walsh, M. F.; Zauderer, M. G.; more...
    Cancer Epidemiology Biomarkers and Prevention (2022)

    Fulltext@MSK | Save
  • Tumor-induced double positive T cells display distinct lineage commitment mechanisms and functions
    Journal Article

    Schad, S. E.; Chow, A.; Mangarin, L.; Pan, H.; Zhang, J.; Ceglia, N.; Caushi, J. X.; Malandro, N.; Zappasodi, R.; Gigoux, M.; more...
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • TCR signal strength defines distinct mechanisms of T cell dysfunction and cancer evasion
    Journal Article

    Shakiba, M.; Zumbo, P.; Espinosa-Carrasco, G.; Menocal, L.; Dündar, F.; Carson, S. E.; Bruno, E. M.; Sanchez-Rivera, F. J.; Lowe, S. W.; Camara, S.; more...
    Journal of Experimental Medicine (2022)

    Fulltext@MSK | Save
  • Tim-4(+) cavity-resident macrophages impair anti-tumor CD8(+) T cell immunity
    Journal Article

    Chow, A.; Schad, S.; Green, M. D.; Hellmann, M. D.; Allaj, V.; Ceglia, N.; Zago, G.; Shah, N. S.; Sharma, S. K.; Mattar, M.; more...
    Cancer Cell (2021)

    Fulltext@MSK | Save
  • Tim-4(+) resident macrophages impair anti-tumor immunity in the serous body cavities by sequestering viable and cytotoxic CD8(+) T cells expressing high levels of phosphatidylserine
    Meeting Abstract

    Chow, A.; Schad, S.; Green, M.; Hellmann, M.; Ceglia, N.; Allaj, V.; Zago, G.; Shah, N.; Sharma, S.; Mattar, M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Protein-altering germline mutations implicate novel genes related to lung cancer development
    Journal Article

    Ji, X.; Mukherjee, S.; Landi, M. T.; Bosse, Y.; Joubert, P.; Zhu, D.; Gorlov, I.; Xiao, X.; Han, Y.; Gorlova, O.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Inherited truncating RAD52 variant discovered using integrated germline-somatic analysis predicts clinical outcome in patients with lung cancers
    Meeting Abstract

    Mukherjee, S.; Srinivasan, P.; Bandlamudi, C.; Hellmann, M. D.; Ravichandran, V.; Selvan, M. E.; Kemel, Y.; Mandelker, D.; Zauderer, M.; Walsh, M.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Clinical activity, tolerability, and long-term follow-up of durvalumab in patients with advanced NSCLC
    Journal Article

    Antonia, S. J.; Balmanoukian, A.; Brahmer, J.; Ou, S. H. I.; Hellmann, M. D.; Kim, S. W.; Ahn, M. J.; Kim, D. W.; Gutierrez, M.; Liu, S. V.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save